Literature DB >> 12899629

Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.

Roberta J Schulte1, Bartholomew M Sefton.   

Abstract

The Wiscott-Aldrich syndrome protein, WASP, is an effector through which cdc42, a Rho family GTPase, regulates the actin cytoskeleton in hematopoietic cells. We have found that WASP binds readily to a number of tyrosine protein kinases including the Src kinases and the Abl kinase when the proteins are coexpressed during transient transfection. Binding inhibited the activity of each of these kinases strikingly, both in vitro and in vivo. Surprisingly, the binding was not due to an interaction between the proline-rich domain of WASP and the SH3 domain of these kinases. Rather, residues 83-93 in WASP were found to bind to the catalytic domains of the kinases. Binding did not decrease the affinity of Src kinases for either ATP or a peptide substrate noticeably. Rather, the V(max) of substrate phosphorylation was reduced by the binding of the peptide. This inhibition represents a novel form of regulation of protein kinase activity and suggests that that the isolation of small molecules that exploit this inhibitory mechanism may be possible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899629     DOI: 10.1021/bi034519u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Binding of Src to Na+/K+-ATPase forms a functional signaling complex.

Authors:  Jiang Tian; Ting Cai; Zhaokan Yuan; Haojie Wang; Lijun Liu; Michael Haas; Elena Maksimova; Xin-Yun Huang; Zi-Jian Xie
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

Review 2.  The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades.

Authors:  Zhichuan Li; Zijian Xie
Journal:  Pflugers Arch       Date:  2008-02-19       Impact factor: 3.657

3.  TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.

Authors:  Ahmed Elmarghani; Hanan Abuabaid; Peter Kjellen
Journal:  Mediators Inflamm       Date:  2010-02-21       Impact factor: 4.711

4.  NaKtide, a Na/K-ATPase-derived peptide Src inhibitor, antagonizes ouabain-activated signal transduction in cultured cells.

Authors:  Zhichuan Li; Ting Cai; Jiang Tian; Joe X Xie; Xiaochen Zhao; Lijun Liu; Joseph I Shapiro; Zijian Xie
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

5.  p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

6.  BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.

Authors:  Welbert O Pereira; Daniel D De Carvalho; Maria Emilia Zenteno; Beatriz F Ribeiro; Jacqueline F Jacysyn; Luiz R Sardinha; Maria A Zanichelli; Nelson Hamerschlak; Gareth E Jones; Katia B Pagnano; Fabiola A Castro; Yolanda Calle; Gustavo P Amarante-Mendes
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.